Journal article icon

Journal article

Systematic review: does concurrent therapy with 5-ASA and immunomodulators in inflammatory bowel disease improve outcomes?

Abstract:

BACKGROUND: With greater use of immunomodulators in inflammatory bowel disease (IBD), it is uncertain whether concurrent therapy with both 5-aminosalicylic acid [5-ASA, mesalazine (mesalamine)] and an immunomodulator is necessary. AIM: To determine whether concurrent therapy with both 5-ASA and immunomodulator(s) improves outcomes in IBD. METHODS: Systematic review with search terms 'azathioprine, 6-mercaptopurine, thiopurine(s), 5 aminosalicylic acid, mesalazine, inflammatory bowel disease,...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


Andrews, JM More by this author
Travis, SP More by this author
Gibson, PR More by this author
Journal:
Alimentary pharmacology and therapeutics
Volume:
29
Issue:
5
Pages:
459-469
Publication date:
2009-03-05
DOI:
EISSN:
1365-2036
ISSN:
0269-2813
URN:
uuid:aef4c820-fbde-4fe8-9ce9-a03da4b9ddb1
Source identifiers:
218412
Local pid:
pubs:218412

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP